Latest Breaking News On - Katherine maynard - Page 1 : comparemela.com
Expert Office Hours offered at RARE Drug Development Symposium
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
The Regulatory Landscape: Pathways, End Points, and Clinical Trials - 2023 RARE Drug Development Symposium
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
The Regulatory Landscape: Pathways, End Points, and Clinical Trials - 2023 RARE Drug Development Symposium panel session
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
RARE-X Announces the Expansion of its Board of Directors to Support the Organization’s Growth and Launch Efforts
Share Article
New members will enhance RARE-X’s programs, pilots, and operational expansion with strategic expertise and leadership
“The additions of Cynthia Grossman, PhD, Jason Colquitt, and Simon Frost to the board are very strategic. All bring a depth of knowledge in patient advocacy, health tech, scaling-up organizations, and operational excellence,” said Nicole Boice, RARE-X Co-Founder/Executive Director. ALISO VIEJO, Calif. (PRWEB) February 10, 2021
RARE-X today announced three new board members who will help support the nonprofit’s work in structured patient data collection, responsible data sharing, and the promise of its Federated Data Sharing Platform for data sharing and analysis. The new board members are Cynthia Grossman, PhD, director at Biogen; Jason Colquitt, CEO of Across